Department of Chemical and Biological Engineering, 3415 Colorado Ave, University of Colorado, Boulder, CO 80309-0596, United States.
Laboratory of Musculoskeletal Tissue Engineering, Massachusetts General Hospital, Boston, MA 021143, United States.
Acta Biomater. 2019 Jul 15;93:97-110. doi: 10.1016/j.actbio.2019.03.046. Epub 2019 Mar 23.
While matrix-assisted autologous chondrocyte implantation has emerged as a promising therapy to treat focal chondral defects, matrices that support regeneration of hyaline cartilage remain challenging. The goal of this work was to investigate the potential of a matrix metalloproteinase (MMP)-sensitive poly(ethylene glycol) (PEG) hydrogel containing the tethered growth factor, transforming growth factor β3 (TGF-β3), and compare cartilage regeneration in vitro and in vivo. The in vitro environment comprised chemically-defined medium while the in vivo environment utilized the subcutaneous implant model in athymic mice. Porcine chondrocytes were isolated and expanded in 2D culture for 10 days prior to encapsulation. The presence of tethered TGF-β3 reduced cell spreading. Chondrocyte-laden hydrogels were analyzed for total sulfated glycosaminoglycan and collagen contents, MMP activity, and spatial deposition of aggrecan, decorin, biglycan, and collagens type II and I. The total amount of extracellular matrix (ECM) deposited in the hydrogel constructs was similar in vitro and in vivo. However, the in vitro environment was not able to support long-term culture up to 64 days of the engineered cartilage leading to the eventual breakdown of aggrecan. The in vivo environment, on the other hand, led to more elaborate ECM, which correlated with higher MMP activity, and an overall higher quality of engineered tissue that was rich in aggrecan, decorin, biglycan and collagen type II with minimal collagen type I. Overall, the MMP-sensitive PEG hydrogel containing tethered TGF-β3 is a promising matrix for hyaline cartilage regeneration in vivo. STATEMENT OF SIGNIFICANCE: Regenerating hyaline cartilage remains a significant clinical challenge. The resultant repair tissue is often fibrocartilage, which long-term cannot be sustained. The goal of this study was to investigate the potential of a synthetic hydrogel matrix containing peptide crosslinks that can be degraded by enzymes secreted by encapsulated cartilage cells (i.e., chondrocytes) and tethered growth factors, specifically TGF-β3, to provide localized chondrogenic cues to the cells. This hydrogel led to hyaline cartilage-like tissue growth in vitro and in vivo, with minimal formation of fibrocartilage. However, the tissue formed in vitro, could not be maintained long-term. In vivo this hydrogel shows great promise as a potential matrix for use in regenerating hyaline cartilage.
虽然基质辅助自体软骨细胞移植已成为治疗局灶性软骨缺损的一种有前途的治疗方法,但支持透明软骨再生的基质仍然具有挑战性。本研究的目的是研究含有基质金属蛋白酶(MMP)敏感的聚乙二醇(PEG)水凝胶的潜力,该水凝胶中含有固定化生长因子转化生长因子β3(TGF-β3),并比较体外和体内的软骨再生。体外环境采用化学定义培养基,体内环境采用无胸腺小鼠的皮下植入模型。猪软骨细胞在二维培养中培养 10 天,然后进行包封。固定化 TGF-β3 可减少细胞铺展。对负载软骨细胞的水凝胶进行总硫酸化糖胺聚糖和胶原含量、MMP 活性以及聚集蛋白聚糖、核心蛋白聚糖、双糖蛋白聚糖和 I 型和 II 型胶原的空间沉积分析。体外和体内水凝胶构建体中沉积的细胞外基质(ECM)总量相似。然而,体外环境无法支持长达 64 天的工程软骨的长期培养,最终导致聚集蛋白聚糖的破坏。另一方面,体内环境导致更精细的 ECM,这与更高的 MMP 活性相关,并导致工程组织的整体质量更高,富含聚集蛋白聚糖、核心蛋白聚糖、双糖蛋白聚糖和 II 型胶原,而 I 型胶原较少。总体而言,含有固定化 TGF-β3 的 MMP 敏感 PEG 水凝胶是体内透明软骨再生的有前途的基质。
再生透明软骨仍然是一个重大的临床挑战。所得修复组织通常为纤维软骨,长期无法维持。本研究的目的是研究一种含有肽交联的合成水凝胶基质的潜力,该交联可以被包封的软骨细胞(即软骨细胞)分泌的酶和固定化生长因子,特别是 TGF-β3,降解,为细胞提供局部软骨形成线索。该水凝胶在体外和体内导致透明软骨样组织生长,形成纤维软骨的程度最小。然而,在体外形成的组织不能长期维持。在体内,这种水凝胶作为再生透明软骨的潜在基质具有很大的潜力。